Evaluation of the use of reporter antigens in an auricular lymph node assay to assess the immunosensitizing potential of drugs.
D000818:Animals; D000941:Antigens / Q000276:immunology*; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D004431:Ear, External / Q000033:anatomy & histology; D005260:Female; D005362:Ficoll / Q000008:administration & dosage / Q000276:immunology; D007114:Immunization / Q000379:methods; D007166:Immunosuppressive Agents / Q000819:agonists* / Q000037:antagonists & inhibitors* / Q000276:immunology; D007271:Injections, Intradermal; D007279:Injections, Subcutaneous; D007370:Interferon Type I / Q000276:immunology / Q000378:metabolism; D007371:Interferon-gamma / Q000276:immunology / Q000378:metabolism; D023441:Local Lymph Node Assay; D008198:Lymph Nodes / Q000033:anatomy & histology; D051379:Mice; D008807:Mice, Inbred BALB C; D015242:Ofloxacin / Q000008:administration & dosage; D010047:Ovalbumin / Q000008:administration & dosage / Q000276:immunology; D010672:Phenytoin / Q000008:administration & dosage; D013420:Sulfamethoxazole / Q000008:administration & dosage; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D000941:Antigens; D007166:Immunosuppressive Agents; D007370:Interferon Type I; D005362:Ficoll; D010672:Phenytoin; D007371:Interferon-gamma; D010047:Ovalbumin; D015242:Ofloxacin; D013420:Sulfamethoxazole